Patents Assigned to CuroGene Life Sciences Co., Ltd.
  • Pharmaceutical composition containing mTOR inhibitor for treating macular degeneration
    Patent number: 10583150
    Abstract: The present invention relates to a pharmaceutical composition for treating macular degeneration, and more particularly to a pharmaceutical composition for treating macular degeneration, which comprises an inhibitor of mTOR gene expression. The pharmaceutical composition according to the present invention can effectively treat age-related macular degeneration, a representative retinal disease that causes blindness in adults.
    Type: Grant
    Filed: March 17, 2017
    Date of Patent: March 10, 2020
    Assignee: CuroGene Life Sciences Co., Ltd.
    Inventors: Young-Ill Lee, Steven Hyun Seung Lee, Tae Kwann Park